Commission Implementing Regulation (EU) 2018/155 of 31 January 2018 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (Text with EEA relevance. )
Date: 2018-01-31
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: chemical product, health risk, market approval, plant health control, plant health product








L_2018029EN.01000801.xml










1.2.2018   


EN


Official Journal of the European Union


L 29/8








            COMMISSION IMPLEMENTING REGULATION (EU) 2018/155
of 31 January 2018
         
amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19, thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 1 January 2022 and 31 December 2024 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.












(2)


In view of the length of the evaluation process for active substances and the recent notification by the United Kingdom pursuant to Article 50 of the Treaty on European Union (3), it is necessary to re-allocate the evaluation of the active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 for which the United Kingdom is the rapporteur Member State or the co-rapporteur Member State, and for which no supplementary dossier has yet been submitted. The active substances concerned are aluminium ammonium sulphate, azoxystrobin, bupirimate, carbetamide, chlormequat, ethylene, fenbuconazole, fluopicolide, fluquinconazole, flutriafol, garlic extract, metazachlor, myclobutanil, paclobutrazol, pepper, plant oils/citronella oil, propaquizafop, quizalofop-p-ethyl, quizalofop-p-tefuryl, tri-allate and urea.












(3)


That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.












(4)


This Regulation should enter into force as soon as possible given that the deadline for the submission of the supplementary dossier for some of the active substances concerned is on 28 February 2018.












(5)


Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.












(6)


The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,





HAS ADOPTED THIS REGULATION:



Article 1
Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.


Article 2
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 31 January 2018.


For the Commission


The President

Jean-Claude JUNCKER
            





(1)  
            OJ L 309, 24.11.2009, p. 1.

(2)  Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5).

(3)  
            OJ C 326, 26.10.2012, p. 13.




ANNEX
The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:






(1)


In Part B, the entries corresponding to active substances Aluminium ammonium sulphate, Azoxystrobin, Bupirimate, Carbetamide, Chlormequat, Ethylene, Fenbuconazole, Fluopicolide, Fluquinconazole, Flutriafol, Garlic extract, Metazachlor, Myclobutanil, Paclobutrazol, Pepper, Plant oils/Citronella oil, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Tri-allate and Urea are replaced by the following corresponding entries:








Active substance




Rapporteur Member State




Co-rapporteur Member State





‘Aluminium ammonium sulphate


IE


PT’




‘Azoxystrobin


AT


NO’




‘Bupirimate


NL


PL’




‘Carbetamide


SE


BE’




‘Chlormequat


AT


IT’




‘Ethylene


NL


ES’




‘Fenbuconazole


SI


AT’




‘Fluopicolide


AT


ES’




‘Fluquinconazole


CZ


SK’




‘Flutriafol


SK


CZ’




‘Garlic extract


IE


DK’




‘Metazachlor


NL


PT’




‘Myclobutanil


AT


ES’




‘Paclobutrazol


AT


RO’




‘Pepper


BE


IE’




‘Plant oils/Citronella oil


FR


CZ’




‘Propaquizafop


AT


EE’




‘Quizalofop-P-ethyl


FI


SE’




‘Quizalofop-P-tefuryl


HR


AT’




‘Tri-allate


NL


CZ’




‘Urea


EL


FI’














(2)


The following Part C is added:

                                 ‘
                                 PART C


ALLOCATION OF THE EVALUATION OF ACTIVE SUBSTANCES WHOSE APPROVAL EXPIRES AFTER 31 DECEMBER 2021 AND NOT LATER THAN 31 DECEMBER 2024
                                 









Active substance




Rapporteur Member State




Co-rapporteur Member State





1,4-Dimethylnaphthalene


AT


PL




Acequinocyl


DE


NL





Adoxophyes orana GV strain BV-0001


DE


FR




Ametoctradin


DE


NL




Aminopyralid


FI


DK




Amisulbrom


EL


FI




Ascorbic acid


NL


FR





Aureobasidium pullulans (strains DSM 14940 and DSM 14941)


AT


DE





Bacillus firmus I-1582


FR


DK





Bacillus pumilus QST 2808


IT


NL




Benalaxyl-M


PT


IT




Benzovindiflupyr


FR


AT




Bixafen


CZ


BE





Candida oleophila strain O


SI


DE




Chlorantraniliprole


IE


DE




Cyflumetofen


ES


AT




Disodium phosphonate


FR


EL




Emamectin


NL


SI




Esfenvalerate


AT


PT




Eugenol


ES


EL




Fenpyrazamine


LV


LT




Flubendiamide


EL


AT




Flumetralin


HU


EL




Fluopyram


AT


HR




Fluxapyroxad


FR


EL




Geraniol


ES


EL




Halosulfuron methyl


IT


PL





Helicoverpa armigera nucleopolyhedrovirus (HearNPV)


EE


FR




Ipconazole


BE


FR




Isopyrazam


NO


EL




lambda-Cyhalothrin


SE


FR




Maltodextrin


IE


FR




Mandipropamid


AT


PT




Metaflumizone


SE


EL




Metam (incl. -potassium and -sodium)


BE


ES




Metobromuron


FR


NO




Metsulfuron-methyl


DK


SE




Orange oil


FR


CZ





Paecilomyces fumosoroseus strain Fe9901


PL


NL




Penflufen


PL


IE




Penthiopyrad


SE


CZ




Phosphane


ES


DE




Potassium phosphonates (formerly potassium phosphite)


FR


EL




Prosulfuron


FR


SK





Pseudomonas sp. Strain DSMZ 13134


NL


BG




Pyridalyl


NL


BE




Pyriofenone


LV


EL




Pyroxsulam


DK


FI




S-Abscisic acid


NL


DK




Sedaxane


FR


AT




Sodium silver thiosulphate


NL


LV




Spinetoram


HR


ES




Spiromesifen


IT


AT




Spirotetramat


AT


NO




Spodoptera littoralis nucleopolyhedrovirus


EE


FR




Streptomyces lydicus WYEC 108


NL


DE




Tembotrione


AT


FR




Thiencarbazone


FR


EL




Thymol


ES


EL





Trichoderma asperellum (strain T34)


SE


IT





Trichoderma atroviride strain I-1237


IT


SK




Valifenalate (formerly Valiphenal)


HU


SI





Zucchini Yellow Mosaik Virus, weak strain


DK


AT’